HealthTree Logo
search more_vert
App Logo
close
person Sign In / Create Account
All Facilities
/
NJ
/
Hackensack - John Theurer Cancer Center
/
James McCloskey 11

Clinical Expertise

Dr. McCloskey's research focus is on phase I/II non-randomized study of birinapant in combination with decitabine in patients with relapsed or refractory myelodysplastic syndrome and acute myelogenous leukemia, and was a primary investigator of cellular and molecular characterization of the immune response and minimal residual disease in patients who have completed treatment for acute myeloid leukemia.

Location

Hackensack - John Theurer Cancer Center : 30 Prospect Ave, Hackensack, NJ 07601, USA

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Jazz Pharmaceuticals
AbbVie
Genentech
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube

 https://www.guidestar.org/profile/45-5354811

HealthTree Foundation / HealthTree for AML is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

Copyright © 2022 HealthTree Foundation. All rights reserved.

Tax ID 45-5354811